Skip to main content
Lancaster Resources Inc. logo

Lancaster Resources Inc. — Investor Relations & Filings

Ticker · LCR ISIN · CA51440M1023 CSE Mining and quarrying
Open in API
Filings indexed 334 across all filing types
Latest filing 2022-05-31 Regulatory Filings
Country CA Canada
Listing CSE LCR

About Lancaster Resources Inc.

https://lancaster-resources.com/

Lancaster Resources Inc. is a mineral exploration company dedicated to discovering and developing high-potential precious metal and critical mineral assets. The company focuses on gold, lithium, uranium, and polymetallic deposits across established mining jurisdictions, including North America and Australia. Key projects include the Lake Cargelligo Gold Project in New South Wales, Australia, and the Trans-Taiga Lithium Pegmatite Project and Lac Iris Polymetallic Property in Quebec. Lancaster emphasizes advancing projects responsibly with a commitment to sustainable environmental practices and long-term value creation.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2022-05-31 English
Notice of the meeting and record date (amended) - English.pdf
Regulatory Filings
2022-05-03 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate by the CFO of NeonMind Biosciences Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended February 28, 2022. The document is primarily a certification letter and does not contain actual financial statements or substantive financial data. It references the interim filings but does not include them. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report itself (IR). The document length is 3056 characters, which is relatively short and consistent with a certification letter rather than a full report.
2022-04-26 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate by the CEO of NeonMind Biosciences Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended February 28, 2022. The document is primarily a certification letter and does not contain actual financial statements or substantive financial data. It references an interim report but does not include the report itself. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than as the interim report (IR). The document length is short (3041 characters), consistent with a certification letter rather than a full report.
2022-04-26 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Condensed Interim Financial Statements' and includes detailed financial statements such as Statements of Financial Position, Operations and Comprehensive Loss, Changes in Shareholders' Equity, and Cash Flows for the three months ended February 28, 2022 and 2021. It is prepared in accordance with IFRS and explicitly states it is unaudited. The document length is about 15,000 characters, indicating it is a full report rather than a brief announcement. The content matches the characteristics of an Interim / Quarterly Report, providing comprehensive financial data for a period shorter than a full fiscal year. There is no indication that this is an announcement or certification only, so it is not Regulatory Filings or Report Publication Announcement. Therefore, the correct classification is Interim / Quarterly Report (IR). Q1 2022
2022-04-26 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Management Discussion and Analysis' (MD&A) and covers the financial position and performance of NeonMind Biosciences Inc. for the three months ended February 28, 2022 and 2021. It includes detailed discussion of financial results, business operations, strategies, and outlook. The text references condensed interim financial statements and audited financial statements, indicating it is a comprehensive financial report for a quarterly period. The length is about 15,000 characters, which is consistent with a substantive report rather than a brief announcement. The content is typical of an Interim / Quarterly Report, containing actual financial data and management's analysis. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q1 2022
2022-04-26 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.